Association of umbilical cord serum TARC/CCL17 with childhood allergies: A birth cohort study
Background: Early identification of infants at high risk of allergies can improve the efficacy of preventive interventions. However, an established quantifiable risk assessment method in the early postnatal period does not exist. TARC (or CCL17) is a Th2 chemokine used as an activity marker for atop...
Main Authors: | Noriko Sato, Fumiya Yamaide, Taiji Nakano, Syuji Yonekura, Yoshitaka Okamoto, Naoki Shimojo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893023000400 |
Similar Items
-
THE CHEMOKINE CCL17/TARC AS A BIOMARKER IN HODGKIN LYMPHOMA
by: Maike Sauer, et al.
Published: (2013-08-01) -
Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
by: Keita Yamashita, et al.
Published: (2023-09-01) -
Thymus and activation-regulated chemokine (TARC)/CCL17 and IgE are associated with elderly asthmatics
by: Kyung Mi Jo, et al.
Published: (2018-05-01) -
The Effect of Suplatast Tosilate on TARC Production in Peripheral Blood Mononuclear Cells and TARC Plasma Levels
by: Shigeki Gorai, et al.
Published: (2005-01-01) -
TARC/CCL17 reflects the severity of pemphigus (pemphigus vulgaris and pemphigus foliaceus) at the initial presentation
by: Tomoya Takegami, et al.
Published: (2024-09-01)